ZLAB
Zai Lab LtdPrice
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Apr 6 ▼ 2 insiders sell $71.7K at $20.45
- May 7 ▼ Zai Lab reported Q1 2026 total revenue of $99.6M, down 6% YoY from $…
- May 10 FDA decision: PDUFA: ZLAB, VYVGART in acetylcholine receptor antibody (A…
- May 13 to May 18 ▼ 4 days of insider sells: $4.1M by 2 insiders, avg $19.95
- May 19 ▼ CEO Du Ying sold $3.3M worth of ZLAB shares over a 5-day window, pri…
- Jun 22 to Jun 30 ▼ 3 days of insider sells: $797.3K by 4 insiders, avg $17.73
- Jul 1 ▲ 1 insider buy $33.1K at $19.05
- Aug 11 to Aug 19 ▼ 3 days of insider sells: $235.1K by 2 insiders, avg $25.06
- Oct 23 ▲ Zai Lab announced a $250M PIPE financing, selling 11.34M ADSs at $22…
- Nov 10 ▲ 1 insider buy $33.4K at $27.19
Signal stack
Where each data set points today.
- InsidersBEARISH
1 insider bought $66.5K at an average $22.42. 4 insiders sold $5.2M.
- InstitutionsMIXED
Q3 2026: 16 added (1 new), 13 trimmed or exited.
- Short sellersSTEADY
Short interest −8.5% to 8.09M shares. 6.7 days to cover, ≈7.2% of shares.
- TrendRANGE
4% below its 50-day average.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| FMR LLC | TRIM | $28.2M |
| Aberdeen Group plc | TRIM | $4.1M |
| ALPS ADVISORS INC | ADD | $3.9M |
| Quadrature Capital Ltd | DOUBLED | $2.3M |
| GEODE CAPITAL MANAGEMENT, LLC | DOUBLED | $1.5M |
| MARSHALL WACE, LLP | TRIM | $995.9K |
| UBS Group AG | TRIM | $925.1K |
| Invesco Ltd. | ADD | $823.1K |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
Last action Aug 2026Price is below the lowest target. Median implies +48%.Targets as of Nov 17, 2026.
| Date | Firm | Rating |
|---|---|---|
| Aug 7, 2026 | Citigroup MAINTAIN | Buy |
Washington
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
GAYNOR RICHARD Director Nov 10, 2026 | BUY | $33.4K |
Chen Yajing Chief Financial Officer Oct 1, 2026 | TAX W/H | $8.0K |
Chen Yajing Chief Financial Officer Oct 1, 2026 | EXERCISE | 920 sh |
Chen Yajing Chief Financial Officer Aug 19, 2026 | SELL | $7.0K |
Chen Yajing Chief Financial Officer Aug 14, 2026 | EXERCISE | 1,250 sh |
Chen Yajing Chief Financial Officer Aug 14, 2026 | TAX W/H | $11.1K |
Lis William Director Aug 12, 2026 | SELL | $212.7K |
Chen Yajing Chief Financial Officer Aug 11, 2026 | SELL | $15.5K |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | -$0.43 | -$0.47–-$0.40 | +17.9% | $112.9M |
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 30, 2026SecBot reports
23 filings · 2 bullish · 5 bearish · 16 neutral- NEUTRAL SC 13G/ANov 16, 2026
RTW Investments, LP filed an amended Schedule 13G disclosing a 9.2% passive stake in Zai Lab Ltd, representing 103,509,730 ordinary shares as of September 30, 2026. This is an increase from the prior filing, but as a passive investor update it is neutral and routine.
🔒 Fresh report (last 24h), subscribers only
- NEUTRAL 8-KNov 5, 2026
Zai Lab reported Q3 2026 total revenue of $108.2M, down 7% YoY from $116.1M, and a GAAP net loss…
Monitor zoci Phase 3 DLLEVATE interim analysis in H2 2027 and the epNEC topline data in H1 2027 for U.S. BLA potential. The $250M capital raise extends runway through key pipeline catalysts but adds…
- BULLISH 8-KOct 23, 2026
Zai Lab announced a $250M PIPE financing, selling 11.34M ADSs at $22.04/ADS to a syndicate of…
The PIPE provides a substantial capital infusion to advance zoci's pivotal program without near-term financing risk. Monitor the registration statement filing (within 15 days of close) and any…
- NEUTRAL CLUSTERAug 21, 2026
Two Zai Lab insiders, Director William Lis and CFO Yajing Chen, sold a combined $220K in…
Ignore this insider cluster. The $220K in sales is noise for a $2.9B company. Monitor ZLAB's next pipeline catalyst (e.g., regulatory updates on VYVGART or ZEJULA) for real trading signals, not…
All ZLAB filing & press-release reports (23)
- SC 13G/A reportNov 16, 2026
- 8-K reportNov 5, 2026
- 8-K reportOct 23, 2026
- CLUSTER reportAug 21, 2026
- CLUSTER reportAug 13, 2026
- CLUSTER reportAug 13, 2026
- 144 reportAug 12, 2026
- CLUSTER reportJul 1, 2026
- CLUSTER reportJun 29, 2026
- INST-CLUSTER reportJun 11, 2026
- 8-K reportMay 21, 2026
- CLUSTER reportMay 19, 2026
- CLUSTER reportMay 19, 2026
- 8-K reportMay 7, 2026
- DEFA14A reportApr 28, 2026
- 144 reportApr 6, 2026
- 144 reportApr 6, 2026
- CLUSTER reportMar 11, 2026
- CLUSTER reportMar 5, 2026
- CLUSTER reportMar 3, 2026
- CLUSTER reportMar 3, 2026
- CLUSTER reportMar 3, 2026
- 8-K reportFeb 26, 2026